MENLO PARK, Calif.--(BUSINESS WIRE)--May 29, 2018--
Intersect ENT, Inc. (Nasdaq: XENT)
today announced that management will present at the 38th
Annual William Blair Growth Stock Conference.
The presentation is scheduled for June 12, 2018 at 11:30 a.m. CT at the
Four Seasons Hotel in Chicago, Ill.
A webcast will be available online from the Investor Relations page of
the company's website at www.IntersectENT.com.
The webcast replay will be available for approximately one month.
About Intersect ENT®
Intersect ENT is dedicated to transforming ear, nose and throat care by
providing innovative, clinically meaningful therapies to physicians and
patients. The company’s steroid releasing implants are designed to
provide mechanical spacing and deliver targeted therapy to the site of
disease. In addition, Intersect ENT is continuing to expand its
portfolio of products based on the company’s unique localized steroid
releasing technology and is committed to broadening patient access to
less invasive and more cost-effective care.
For additional information on the company or its products, including
risks and benefits, please visit www.IntersectENT.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180529005156/en/
Source: Intersect ENT
Jeri Hilleman, 650-641-2105